This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Sep;48(9):3642; author reply 3642-3.

doi: 10.1128/AAC.48.9.3642-3643.2004.

Moxifloxacin treatment of tuberculosis

Roland Gosling, Stephen Gillespie

PMID: 15328148
PMCID: PMC514750
DOI: 10.1128/AAC.48.9.3642-3643.2004

Comment

Moxifloxacin treatment of tuberculosis

Roland Gosling et al. Antimicrob Agents Chemother. 2004 Sep.

. 2004 Sep;48(9):3642; author reply 3642-3.

doi: 10.1128/AAC.48.9.3642-3643.2004.

Authors

Roland Gosling, Stephen Gillespie

PMID: 15328148
PMCID: PMC514750
DOI: 10.1128/AAC.48.9.3642-3643.2004

No abstract available

PubMed Disclaimer

Comment on

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
Pletz MW, De Roux A, Roth A, Neumann KH, Mauch H, Lode H. Pletz MW, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):780-2. doi: 10.1128/AAC.48.3.780-782.2004. Antimicrob Agents Chemother. 2004. PMID: 14982764 Free PMC article. Clinical Trial.

Similar articles

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
Pletz MW, De Roux A, Roth A, Neumann KH, Mauch H, Lode H. Pletz MW, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):780-2. doi: 10.1128/AAC.48.3.780-782.2004. Antimicrob Agents Chemother. 2004. PMID: 14982764 Free PMC article. Clinical Trial.
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
Gillespie SH, Gosling RD, Uiso L, Sam NE, Kanduma EG, McHugh TD. Gillespie SH, et al. J Antimicrob Chemother. 2005 Dec;56(6):1169-71. doi: 10.1093/jac/dki376. Epub 2005 Oct 13. J Antimicrob Chemother. 2005. PMID: 16223939
Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.
Ginsburg AS, Lee J, Woolwine SC, Grosset JH, Hamzeh FM, Bishai WR. Ginsburg AS, et al. Antimicrob Agents Chemother. 2005 Feb;49(2):853-6. doi: 10.1128/AAC.49.2.853-856.2005. Antimicrob Agents Chemother. 2005. PMID: 15673788 Free PMC article.
Moxifloxacin.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):127-31. doi: 10.1016/S1472-9792(08)70016-7. Tuberculosis (Edinb). 2008. PMID: 18486050 Review. No abstract available.
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].
Lounis N, Guillemont J, Veziris N, Koul A, Jarlier V, Andries K. Lounis N, et al. Med Mal Infect. 2010 Jul;40(7):383-90. doi: 10.1016/j.medmal.2009.09.007. Epub 2009 Dec 1. Med Mal Infect. 2010. PMID: 19954909 Review. French.

See all similar articles

Cited by

New drugs and regimens for treatment of TB.
Leibert E, Rom WN. Leibert E, et al. Expert Rev Anti Infect Ther. 2010 Jul;8(7):801-13. doi: 10.1586/eri.10.60. Expert Rev Anti Infect Ther. 2010. PMID: 20586565 Free PMC article. Review.
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D, Day J, Chau TT, Dung NH, Yen NT, Bang ND, Merson L, Olliaro P, Pouplin T, Caws M, Wolbers M, Farrar J. Heemskerk D, et al. Trials. 2011 Feb 2;12:25. doi: 10.1186/1745-6215-12-25. Trials. 2011. PMID: 21288325 Free PMC article. Clinical Trial.

References

1. Gillespie, S. H., R. D. Gosling, and B. M. Charalambous. 2002. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. Am. J. Respir. Crit. Care Med. 166:31-35. - PubMed
1. Gosling, R. D., L. Heifets, and S. H. Gillespie. 2003. A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs. J. Antimicrob. Chemother. 52:473-476. - PubMed
1. Gosling, R. D., L. O. Uiso, N. E. Sam, E. Bongard, E. G. Kanduma, M. Nyindo, R. W. Morris, and S. H. Gillespie. 2003. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 168:1342-1345. (First published 13 August 2003; 10.1164/rccm.200305-682OC.) - PubMed
1. Hafner, R., J. Cohn, D. Wright, N. Dunlap, M. Egorin, M. Enama, K. Muth, C. Peloquin, N. Mor, L. Heifits, and the DATRI 008 Study Group. 1997. Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. Am. J. Respir. Crit. Care Med. 156:918-923. - PubMed
1. Jindani, A., V. Aber, E. Edwards, and D. Mitchison. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121:939-949. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information